Related references
Note: Only part of the references are listed.Production of IL-27 in Multiple Sclerosis Lesions by Astrocytes and Myeloid Cells: Modulation of Local Immune Responses
Vincent Senecal et al.
GLIA (2016)
An IL-27/Lag3 axis enhances Foxp3(+) regulatory T cell-suppressive function and therapeutic efficacy
J-s Do et al.
MUCOSAL IMMUNOLOGY (2016)
Interleukin-27-Producing CD4+ T Cells Regulate Protective Immunity during Malaria Parasite Infection
Daisuke Kimura et al.
IMMUNITY (2016)
Elevated interleukin-27 levels in human neonatal macrophages regulate indoleamine dioxygenase in a STAT-1 and STAT-3-dependent manner
Joo-Yong Jung et al.
IMMUNOLOGY (2016)
IL-27-induced modulation of autoimmunity and its therapeutic potential
Rakeshchandra R. Meka et al.
AUTOIMMUNITY REVIEWS (2015)
Interleukin-27 ameliorates coxsackievirus-B3-induced viral myocarditis by inhibiting Th17 cells
Hengshan Zhu et al.
VIROLOGY JOURNAL (2015)
Global Health: Global Effects of Smoking, of Quitting, and of Taxing Tobacco
Prabhat Jha et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
IL-27 controls sepsis-induced impairment of lung antibacterial host defence
Ju Cao et al.
THORAX (2014)
Persistence of Th17/Tc17 Cell Expression upon Smoking Cessation in Mice with Cigarette Smoke-Induced Emphysema
Min-Chao Duan et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
Increased expression of CD4+IL-17+ cells in the lung tissue of patients with stable chronic obstructive pulmonary disease (COPD) and smokers
Jianquan Zhang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2013)
The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK
Kirstin Pirie et al.
LANCET (2013)
50-Year Trends in Smoking-Related Mortality in the United States
Michael J. Thun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
21st-Century Hazards of Smoking and Benefits of Cessation in the United States
Prabhat Jha et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
IL-27 Receptor Signalling Restricts the Formation of Pathogenic, Terminally Differentiated Th1 Cells during Malaria Infection by Repressing IL-12 Dependent Signals
Ana Villegas-Mendez et al.
PLOS PATHOGENS (2013)
IL-27 Is Elevated in Patients With COPD and Patients With Pulmonary TB and Induces Human Bronchial Epithelial Cells to Produce CXCL10
Ju Cao et al.
CHEST (2012)
The Cytokines Interleukin 27 and Interferon-γ Promote Distinct Treg Cell Populations Required to Limit Infection-Induced Pathology
Aisling O'Hara Hall et al.
IMMUNITY (2012)
Impact of smoking on mortality and life expectancy in Japanese smokers: a prospective cohort study
R. Sakata et al.
BRITISH MEDICAL JOURNAL (2012)
Th17 Cells Induce Colitis and Promote Th1 Cell Responses through IL-17 Induction of Innate IL-12 and IL-23 Production
Ting Feng et al.
JOURNAL OF IMMUNOLOGY (2011)
Essential Role for IL-27 Receptor Signaling in Prevention of Th1-Mediated Immunopathology during Malaria Infection
Emily Gwyer Findlay et al.
JOURNAL OF IMMUNOLOGY (2010)
Late Developmental Plasticity in the T Helper 17 Lineage
Yun Kyung Lee et al.
IMMUNITY (2009)
Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice
David Bending et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
IL-27 Blocks RORc Expression to Inhibit Lineage Commitment of Th17 Cells
Caroline Diveu et al.
JOURNAL OF IMMUNOLOGY (2009)
IL-27 induces a Th1 immune response and susceptibility to experimental arthritis
Yanxia Cao et al.
JOURNAL OF IMMUNOLOGY (2008)
Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells
Marcel Batten et al.
JOURNAL OF IMMUNOLOGY (2008)
A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells
Amit Awasthi et al.
NATURE IMMUNOLOGY (2007)
Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system
Jason S. Stumhofer et al.
NATURE IMMUNOLOGY (2006)
Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells
Marcel Batten et al.
NATURE IMMUNOLOGY (2006)
Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27
Stefan Wirtz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
IL-27 suppresses CD28-medicated IL-2 production through suppressor of cytokine signaling 3
Toshiyuki Owaki et al.
JOURNAL OF IMMUNOLOGY (2006)
Positive and negative regulation of the IL-27 receptor during lymphoid cell activation
AV Villarino et al.
JOURNAL OF IMMUNOLOGY (2005)
IL-27 subunits and its receptor (WSX-1) mRNAs are markedly up-regulated in inflammatory cells in the CNS during experimental autoimmune encephalomyelitis
JF Li et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27
S Pflanz et al.
JOURNAL OF IMMUNOLOGY (2004)
An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema
S Grumelli et al.
PLOS MEDICINE (2004)
CD4 T lymphocyte-mediated lung disease - Steady state between pathological and tolerogenic immune reactions
D Bruder et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Understanding the pro- and anti-inflammatory properties, of IL-27
AV Villarino et al.
JOURNAL OF IMMUNOLOGY (2004)
The role of IL-27 in the development of T-cell responses during parasitic infections
CA Hunter et al.
IMMUNOLOGICAL REVIEWS (2004)
IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms
S Lucas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Cutting edge: Role of IL-27/WSX-1 signaling for induction of T-Bet through activation of STAT1 during initial Th1 commitment
A Takeda et al.
JOURNAL OF IMMUNOLOGY (2003)
IL-27, a heterodimeric cytokine composed of EB13 and p28 protein, induces proliferation of naive CD4+ T cells
S Pflanz et al.
IMMUNITY (2002)
Inflammation of the airways and lung parenchyma in COPD
MG Cosio et al.
CHEST (2002)
Share Paper
